Haematology & Transfusion Science

Experimental cancer blood test

A new method of analysing cancer patients’ blood for evidence of the disease could be up to 10 times more sensitive than previous methods, according to new research.

Emergency morphology

Professor Barbara J Bain covers some of the circumstances when blood films are vital.

External quality assesment in a pandemic

What impact has the lockdown had on UK NEQAS and the services it provides? Barbara De la Salle, Director of UK NEQAS Haematology, and colleagues explain.

Drive-through phlebotomy

Laboratory Manager Richard Wardle outlines the introduction of a drive-through phlebotomy service during the COVID-19 pandemic.

Glucose-sensing neurons regulate blood sugar

Low blood sugar levels, known as hypoglycaemia, can be a life-threatening situation, especially for people with type 1 diabetes who rely on intensive insulin therapy to prevent blood sugar from going too high.

Setting up a Nightingale hospital transfusion service

Alison Muir, a Lead Scientist in Blood Transfusion, discusses the issues and challenges in setting up a transfusion service to help cope with the pandemic.

Convalescent plasma therapy

A US team of Johns Hopkins experts has created a clinical guidebook to help hospitals and medical centres rapidly scale up their ability to deliver so-called convalescent plasma therapy, which leverages immune system components found in the plasma portion of blood from people who have recovered from COVID-19.

Blood on board

Blood Bank and Stem Cell Bank Discipline Manager Beverly Craig outlines an innovative project with the emergency services.

Clinical trial for rare blood disease

An international team has reported the use of a stem cell gene therapy to treat nine people with the rare, inherited blood disease known as X-linked chronic granulomatous disease (X-CGD). 

Top